These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22353238)

  • 1. Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review.
    Ku JH; Godoy G; Amiel GE; Lerner SP
    BJU Int; 2012 Sep; 110(5):630-6. PubMed ID: 22353238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of urine-based survivin mRNA test using reverse transcription-polymerase chain reaction for bladder cancer: a systematic review.
    Xia Y; Liu YL; Yang KH; Chen W
    Chin J Cancer; 2010 Apr; 29(4):441-6. PubMed ID: 20346223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive values of urinary bladder tumor markers survivin and soluble-Fas comparison with cystoscopy and bladder tumor antigen.
    Ganas V; Kalaitzis C; Sountoulides P; Giannakopoulos S; Touloupidis S
    Minerva Urol Nefrol; 2012 Dec; 64(4):279-85. PubMed ID: 23288215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic role of survivin in urinary bladder cancer.
    Srivastava AK; Singh PK; Srivastava K; Singh D; Dalela D; Rath SK; Goel MM; Brahma Bhatt ML
    Asian Pac J Cancer Prev; 2013; 14(1):81-5. PubMed ID: 23534808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bladder cancer screening with urine-based tumour markers - occupational medical experience].
    Nasterlack M; Feil G; Leng G; Pesch B; Huber S; Sievert KD; Johnen G; Taeger D; Mayer T; Kluckert M; Brüning T; Stenzl A
    Aktuelle Urol; 2011 Mar; 42(2):128-34. PubMed ID: 21437837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of combined use of survivin mRNA and matrix metalloproteinase 2 and 9 for bladder cancer detection in voided urine.
    Eissa S; Badr S; Elhamid SA; Helmy AS; Nour M; Esmat M
    Dis Markers; 2013; 34(1):57-62. PubMed ID: 22960341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a New Survivin ELISA and UBC
    Gleichenhagen J; Arndt C; Casjens S; Meinig C; Gerullis H; Raiko I; Brüning T; Ecke T; Johnen G
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
    BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of urinary survivin as a diagnostic marker in bladder cancer.
    Abd El-Hakim TF; El-Shafie MK; Abdou AG; Azmy RM; El-Naidany SS; Badr El-Din MO
    Anal Quant Cytopathol Histpathol; 2014 Jun; 36(3):121-7. PubMed ID: 25141488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer.
    Shariat SF; Casella R; Khoddami SM; Hernandez G; Sulser T; Gasser TC; Lerner SP
    J Urol; 2004 Feb; 171(2 Pt 1):626-30. PubMed ID: 14713774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE SIGNIFICANCE OF EPIDERMAL GROWTH FACTOR RECEPTOR AND SURVIVIN EXPRESSION IN BLADDER CANCER TISSUE AND URINE CYTOLOGY OF PATIENTS WITH TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER.
    Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A
    East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of urinary survivin mRNA expression detected by RT-PCR compared with urine cytology in the detection of bladder cancer: A meta-analysis of diagnostic test accuracy in head-to-head studies.
    Fu L; Zhang J; Li L; Yang Y; Yuan Y
    Oncol Lett; 2020 Feb; 19(2):1165-1174. PubMed ID: 31966046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis.
    Dong F; Shen Y; Xu T; Wang X; Gao F; Zhong S; Chen S; Shen Z
    World J Surg Oncol; 2018 Mar; 16(1):61. PubMed ID: 29562940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancer.
    Eissa S; Badr S; Barakat M; Zaghloul AS; Mohanad M
    Clin Lab; 2013; 59(7-8):893-900. PubMed ID: 24133921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine detection of survivin and diagnosis of bladder cancer.
    Smith SD; Wheeler MA; Plescia J; Colberg JW; Weiss RM; Altieri DC
    JAMA; 2001 Jan; 285(3):324-8. PubMed ID: 11176843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of combined detection of urinary Livin and Survivin mRNA expression in the early diagnosis of bladder cancer].
    Jiang LL; Xie MM; Wang XR; Zhao Y; Wang ZJ
    Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(44):3520-2. PubMed ID: 24521893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.
    Herman MP; Svatek RS; Lotan Y; Karakiewizc PI; Shariat SF
    Minerva Urol Nefrol; 2008 Dec; 60(4):217-35. PubMed ID: 18923359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies.
    Liang Z; Xin R; Yu Y; Wang R; Wang C; Liu X
    World J Urol; 2018 Sep; 36(9):1373-1381. PubMed ID: 29610963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor markers in the diagnosis of primary bladder cancer. A systematic review.
    Glas AS; Roos D; Deutekom M; Zwinderman AH; Bossuyt PM; Kurth KH
    J Urol; 2003 Jun; 169(6):1975-82. PubMed ID: 12771702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of BTAstat, NMP22, HA, survivin, CD44v6, vEGF and VUC in bladder cancer diagnosis].
    Sun Y; He H; Ma Q; Wang XY; Yang L; He DL
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2507-12. PubMed ID: 16321281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.